Navigation Links
S1 Biopharma Supports FDA Advisory Committee's Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder
Date:6/5/2015

NEW YORK, June 5, 2015 /PRNewswire/ -- Yesterday's FDA Advisory Committee recommendation for the approval of flibanserin was a landmark step for women's health, addressing the important unmet medical need for women living with hypoactive sexual desire disorder, or HSDD.  We are especially pleased for S1 Biopharma's Dr. Robert Pyke who fathered flibanserin at Boehringer Ingelheim before it was acquired by Sprout Pharmaceuticals.  Dr. Pyke joined S1 Biopharma as Chief Medical Officer in 2012 to develop our next-generation drug for HSDD, Lorexys.

HSDD is a medical condition marked by a lack of sexual thoughts and desire for sexual activity that cannot be accounted for by another medical, physical, or psychiatric condition, or medication.  An estimated 1 in 10 women may have HSDD at some point in their life, for which therapies like flibanserin with a 9%- 13% responder rate over placebo, and S1 Biopharma's first in class, next-generation drug Lorexys have been developed to address.

S1 Biopharma is currently preparing for upcoming Phase IIb studies for Lorexys for the treatment of HSDD.  In its recently completed Phase IIa study, Lorexys demonstrated a 76% responder rate that was 38% greater than control.

About S1 Biopharma

S1 Biopharma is a developer of first-in-class drugs for sexual dysfunction in both women and men. The company's pipeline of therapies is non-hormonal, acting on the sexual centers of the brain by restoring the natural balance of key neurotransmitters. S1 Biopharma's pipeline utilizes its trademark philosophy of identifying and combining mechanistically opposing agents that work synergistically to maximize beneficial effects on sexual function while minimizing side effects. The company's lead compound, Lorexys, recently completed a Phase IIa clinical trial for the treatment of hypoactive sexual desire disorder (HSDD).

For more information please visit www.s1biopharma.com.

Contact:
Nick Sitchon
nsitchon@s1biopharma.com
212-895-8915


'/>"/>
SOURCE S1 Biopharma
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma
2. EMD Millipore Introduces Compaction Technology to Improve Solubility and Facilitate Handling of Cell Culture Media Used in Biopharmaceutical Production
3. Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting
4. PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference
5. Array BioPharma To Present At The Jefferies 2015 Global Healthcare Conference
6. Technical Coverage on Biotech Stocks -- Anthera Pharma, RXi Pharma, MiMedx, Sarepta Therapeutics, and Navidea Biopharma
7. Intarcia Named To "CNBC Disruptor 50" List: One Of Only Two Biopharma Companies Named
8. DS Biopharma to Present at UBS Global Healthcare Conference
9. WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition
10. CTI BioPharma Reports First Quarter 2015 Financial Results
11. PDL BioPharma Announces First Quarter 2015 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2018)... ... October 11, 2018 , ... doeLEGAL, a leading provider of ... law firms, today announced it is sponsoring the 2018 ACC Annual Meeting in ... corporate legal departments are using smart data, intelligently delivered to rethink data strategies ...
(Date:10/11/2018)... ... ... In the last four months it has also obtained grant of its own ... in USA, China and Japan from three other patent families covering the magnetic detection ... The patents assigned from QinetiQ include US 7113092, titled “Ferromagnetic Object Detector” which relates ...
(Date:10/7/2018)... ... October 07, 2018 , ... No one likes to think about an emergency, even what ... disruptive to a family. The local ServPro professional, a trusted leader in the restoration industry, ... an emergency. , No time is a good time for an emergency, but having ...
Breaking Medicine Technology:
(Date:10/18/2018)... ... October 18, 2018 , ... ... cancer and hematology, and a comprehensive Women’s Center, Mount Sinai Doctors Long Island ... at 5 Cuba Hill Road in Greenlawn, Suffolk County. , With highly-trained ...
(Date:10/18/2018)... ... October 18, 2018 , ... InVivo ... automated preclinical image data analysis tool, InVivoAX™, for quantitative bioluminescence tomography using ... preclinical imaging of small animal models of human disease. The research article ...
(Date:10/17/2018)... Calif. (PRWEB) , ... October 17, 2018 , ... The Myers’ have been ... p.m. at their office, 11141 Tampa Ave., Northridge, CA 91326. , “The Harvest Festival ... at the same time help the kids at Children’s Hospital LA,” said Kris and Keith. ...
(Date:10/16/2018)... ... October 16, 2018 , ... Bastyr University is pleased ... Integrative Health and Medicine’s (AIHM) Visionary Award for his passionate efforts in forging ... was selected as AIHM’s recipient of the Visionary Award due to his tireless ...
(Date:10/16/2018)... ... October 16, 2018 , ... Sheba Vine, JD, CPCO, ... employment law, writes frequently on employment law matters and has contributed articles to ... the Health Care Compliance Professional's Manual titled “Navigating the Evolving Marijuana Landscape” to ...
Breaking Medicine News(10 mins):